| Issue Date | Title | Author(s) |
| 2022 | Aldosterone synthase CYP11B2 (-344C/T) gene polymorphism influences risk of chronic kidney disease in patients with arterial hypertension | Dzhuryak, V.; Sydorchuk, A.; Voroniuk, K.; Sydorchuk, L.; Repchuk, Yu.; Semianiv, M.; Sydorchuk, R.; Sydorchuk, I.; Iftoda, O. |
| 2022 | Dependence of metabolic disorders on aldosterone synthase CYP11B2 (-344C/T) gene polymorphism in hypertensive patients | Dzhuryak, V.; Sydorchuk, L.; Repchuk, Yu.; Semianiv, M.; Voroniuk, K.; Sydorchuk, I.; Iftoda, O.; Sydorchuk, R. |
| 2023 | Dyslipidemia and hyperglycemia in hypertensive patients associate with GNB3 (rs5443) and NOS3 (rs2070744) genes’ allelic state | Sydorchuk, A.; Sydorchuk, L.; Voroniuk, K.; Semianiv, M.; Sydorchuk, R.; Kushnir, O. |
| 2014 | Endothelial dysfunction and system inflammatory response markers in hypertensive patients with acute myocardial infarction depending on polymorphism of ACE (I/D) and eNOS (894G>T) | Sydorchuk, A.; Sydorchuk, R.; Sydorchuk, L.; Amosova, K.M.; Sydorchuk, I.; Ursuliak, U. |
| 2022 | Endothelial nitric oxide synthase gene polymorphism (894G>T, 786T>C) contribute to hypertension risk and lipids profile disorders | Dzhuryak, V.; Sydorchuk, A.; Sydorchuk, L.; Sydorchuk, R.; Sydorchuk, I.; Iftoda, O. |
| 2013-05 | Etiology of acute pyelonephritis: species composition and populational levels of urine microflora | Stepan, V.; Fedoruk, O.S.; Sydorchuk, L.; Viznyuk, V.; Sydorchuk, R. |
| 2023 | Hypertension and antihypertensive therapy impair respiratory function | Dzhuryak, V.; Sydorchuk, L.; Voroniuk, K.; Sydorchuk, R.; Petrynych, O.; Kazantseva, T.; Sokolenko, A.; Yarynych, Yu.; Kushnir, O. |
| 2023 | Hypertension-related impairment of mesenteric endothelial function contributes into Gut-Liver axis via intestinal dysbiosis and Hepatic Steatosis, and associates with genetic dysre | Dzhuryak, V.; Sydorchuk, L.; Voroniuk, K.; Sydorchuk, R.; Sokolenko, A.; Repchuk, Yu.; Semianiv, M.; Yarynych, Yu.; Iftoda, O. |
| 2023 | Immune and metabolic disorders in hypertension, obesity, and hepatic steatosis associate with PPAR-gamma2 Pro12ala and ACE I/D genes’ polymorphisms | Dzhuriak, V.; Sydorchuk, L.; Voroniuk, K.; Sydorchuk, R.; Sokolenko, A.; Repchuk, Yu.; Semianiv, M.; Iftoda, O. |
| 2013 | Lipopolysaccharide induces neovascularization and immunosuppression, and must be considered as therapentic target | Sydorchuk, L.; Fomin, P.; Sydorchuk, R.; Sydorchuk, I.; Plehutsa, O.; Sydorchuk, A. |
| 2010 | Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients | Sydorchuk, L.; Amosova, K.M.; Sydorchuk, R.; Ursuliak, U.; Sydorchuk, I. |
| 2023 | Risk of endothelial dysfunction and carotid arteries intima media thickness depending on guanine nucleotide-binding protein beta-3 and endothelial nitric oxide synthase genes’ po | Sydorchuk, A.; Voroniuk, K.; Sydorchuk, L.; Dzhuriak, V.; Sydorchuk, R.; Gutnitska, A.; Iftoda, O. |
| 2013 | Why targeting vascular endothelial growth factor is not sufficiently effective? | Plehutsa, O.; Sydorchuk, A.; Fomin, P.; Sydorchuk, I.; Sydorchuk, R.; Sydorchuk, L.; Levites, S.; Vinohradskyy, A. |
